| 来源类型 | Working Paper |
| 规范类型 | 报告 |
| DOI | 10.3386/w28127 |
| 来源ID | Working Paper 28127 |
| The Value of a Cure: An Asset Pricing Perspective | |
| Viral V. Acharya; Timothy Johnson; Suresh Sundaresan; Steven Zheng | |
| 发表日期 | 2020-11-23 |
| 出版年 | 2020 |
| 语种 | 英语 |
| 摘要 | We provide an estimate of the value of a cure using the joint behavior of stock prices and a vaccine progress indicator during the ongoing COVID-19 pandemic. Our indicator is based on the chronology of stage-by-stage progress of individual vaccines and related news. We construct a general equilibrium regime-switching model of repeated pandemics and stages of vaccine progress wherein the representative agent withdraws labor and alters consumption endogenously to mitigate health risk. The value of a cure in the resulting asset-pricing framework is intimately linked to the relative labor supply across states. The observed stock market response to vaccine progress serves to identify this quantity, allowing us to use the model to estimate the economy-wide welfare gain that would be attributable to a cure. In our estimation, and with standard preference parameters, the value of the ability to end the pandemic is worth 5-15% of total wealth. This value rises substantially when there is uncertainty about the frequency and duration of pandemics. Agents place almost as much value on the ability to resolve the uncertainty as they do on the value of the cure itself. This effect is stronger – not weaker – when agents have a preference for later resolution of uncertainty. The policy implication is that understanding the fundamental biological and social determinants of future pandemics may be as important as resolving the immediate crisis. |
| 主题 | Microeconomics ; General Equilibrium ; Financial Economics ; Portfolio Selection and Asset Pricing ; Health, Education, and Welfare ; Health ; Environmental and Resource Economics ; Environment ; COVID-19 |
| URL | https://www.nber.org/papers/w28127 |
| 来源智库 | National Bureau of Economic Research (United States) |
| 引用统计 | |
| 资源类型 | 智库出版物 |
| 条目标识符 | http://119.78.100.153/handle/2XGU8XDN/585801 |
| 推荐引用方式 GB/T 7714 | Viral V. Acharya,Timothy Johnson,Suresh Sundaresan,et al. The Value of a Cure: An Asset Pricing Perspective. 2020. |
| 条目包含的文件 | ||||||
| 文件名称/大小 | 资源类型 | 版本类型 | 开放类型 | 使用许可 | ||
| w28127.pdf（722KB） | 智库出版物 | 限制开放 | CC BY-NC-SA | 浏览 | ||
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。
